BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Pharm Country

  TapImmune Inc. CEO Featured in Exclusive Interview

  July 6, 2007

   · 

  2 min read
• Drug Development

  Tibotec Therapeutics New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV

  July 6, 2007

   · 

  11 min read
• Biotech Bay

  SuperGen, Inc. to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

  July 6, 2007

   · 

  1 min read
• Drug Development

  Tibotec Pharmaceuticals Ltd Release: TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials

  July 6, 2007

   · 

  5 min read
• Policy

  Applied Nanoscience Enters into Litigation Settlement Agreement

  July 6, 2007

   · 

  1 min read
• Drug Development

  Genzyme Corporation’s Diarrhea Drug Tolevamer Fails Phase 3 Trial

  July 6, 2007

   · 

  5 min read
• Aescap Venture Invests Eur 4 Million in Dutch Biotech Company, To-BBB technologies BV

  July 6, 2007

   · 

  1 min read
• Deals

  China’s Fosun International Ltd. Prices $1.5 Billion HK IPO at Top of Range

  July 6, 2007

   · 

  1 min read
• Deals

  Australia’s Sonic Healthcare Ltd. to Buy US Lab for Up to $168 Million

  July 6, 2007

   · 

  1 min read
• Imperial Innovations Spin-out, NanoBioDesign Limited, Secures Investment for Novel Drug Discovery Technology

  July 6, 2007

   · 

  6 min read